What is Theravance Biopharma's income tax?

Theravance Biopharma (TBPH) reported income tax of -$1.54M in Q1 2026.

How has Theravance Biopharma's income tax changed year-over-year?

Theravance Biopharma's income tax decreased by 175.0% year-over-year, from -$559K to -$1.54M.

What is the long-term trend for Theravance Biopharma's income tax?

Over 3 years (2021 to 2025), Theravance Biopharma's income tax has grown at a 436.8% compound annual growth rate (CAGR), from -$151K to $23.35M.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Theravance Biopharma TBPH Income Tax

Income Tax at other companies

Zevra Therapeutics, Inc.ZVRA

$6.91M+485%

LQD

Liquidia CorporationLQDA

$3.92M—

Royalty PharmaRPRX

$0—

United TherapeuticsUTHR

$43.4M-57.2%

Aurinia PharmaceuticalsAUPH

$9.57M+852%

PrecigenPGEN

$0—

Segments

By segment

See full

Single Reportable-$1.54M-175%

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's income tax?: Theravance Biopharma (TBPH) reported income tax of -$1.54M in Q1 2026.
How has Theravance Biopharma's income tax changed year-over-year?: Theravance Biopharma's income tax decreased by 175.0% year-over-year, from -$559K to -$1.54M.
What is the long-term trend for Theravance Biopharma's income tax?: Over 3 years (2021 to 2025), Theravance Biopharma's income tax has grown at a 436.8% compound annual growth rate (CAGR), from -$151K to $23.35M.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.